참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Hydrochloric Acid | HCID 313 | — |
| 반응물 | Ethyl bromoacetate | HCID 7748 | — |
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | HCID 178526457 | HCID 178526457 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | Ethyl 3-chloro-6-nitroindazol-1-ylacetate | HCID 19086706 | 56.6% |
반응 단계
3-chloro-6-nitroindazole (20 g) was dissolved in dry DMF (180cm3) and the solution cooled to 5° C. 50% sodium hydride (4.86 g) was added portionwise with stirring and cooling between 5° and 10° C. and then for an additional 15 minutes. Ethyl bromoacetate (16.91 g) was added slowly at 5° C., the reaction mixture warming to 30° C. The reaction mixture was then stirred at 20° C. for four hours. Water (lL) was added and the mixture acidified with diluted hydrochloric acid, shaken with ethyl acetate and filtered through hyflo. The organic phase was separated from the filtrate and the aqueous phase extracted (×2) with ethyl acetate. The combined organic phase was washed with water, dried (MgSO4) filtered and the solvent removed from the filtrate under vacuum. The residue was purified by flash chromatography (SiO2 ; hexane: TBME, 7:3 and then chloroform:ethyl acetate 95:5) to give ethyl 3-chloro-6-nitroindazol-1-ylacetate (16.25 g) as a pale yellow solid m.pt 109.1°-110.3° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05306692 |
|---|
| 출처 데이터셋 | uspto-grants-1994_04 |
|---|
| ORD ID | ord-afbdf5edbd7e49f1a8c3810ab5fc418a |
|---|
| 출처 메모 | uspto-grants-1994_04 |
|---|